Solubility enhancement of trans-chalcone using lipid carriers and supercritical CO2 processing

Journal of Supercritical Fluids

Volumn 48, Issue 2, 2009, Pages 120-125

  Sampaio de Sousa, A R ^a   Silva, Rodrigo ^b   Tay, Feng H ^c   Simplício, Ana Luísa ^a,b   Kazarian, Sergei G ^c   Duarte, Catarina M M ^a,b  

^a INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^b INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLÓGICA   (Portugal)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

ATR FTIR imaging; Chalcone; Lipid carriers; Supercritical fluids

Indexed keywords

CARBON DIOXIDE; EFFLUENT TREATMENT; FOURIER TRANSFORM INFRARED SPECTROSCOPY; MELTING POINT; SCANNING ELECTRON MICROSCOPY; SUPERCRITICAL FLUIDS; TERNARY SYSTEMS;

ATR-FTIR IMAGING; ATTENUATED TOTAL REFLECTIONS; BULK MIXTURES; CHALCONE; CHALCONES; CORE STRUCTURES; DEPRESSURIZATION; FOURIER; INTESTINAL FLUIDS; LASER DIFFRACTIONS; LIPID CARRIERS; MELTING TEMPERATURES; MICROPARTICLES; SATURATED SOLUTIONS; SEM; SOLUBILITY ENHANCEMENTS; SOLUBILITY TESTS; SPECTROSCOPIC IMAGING; SUPERCRITICAL CO; WORK STUDIES;

SOLUBILITY;

EID: 63749123206     PISSN: 08968446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.supflu.2008.09.025     Document Type: Article

References (36)

1. Mehnert W., and Mäder K. Solid lipid nanoparticles: production, characterization and applications. Advanced Drug Delivery Reviews 47 (2001) 165-196
2. Hertault B., Saulnier P., Pech B., Proust J.-E., and Benoit J.-P. Physico-chemical stability of colloidal lipid particles. Biomaterials 24 (2003) 4283-4300
3. Düzgünes N. Lipid assemblies for drug delivery. Advanced Drug Delivery Reviews 47 (2001) 137-138
4. Chen H., Chang X., Du D., Liu W., Liu J., Weng T., Yang Y., Xu H., and Yang X. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. Journal of Controlled Release 110-2 (2006) 296-306
5. Yener G., Incegül T., and Yener N. Importance of using solid lipid microspheres as carriers for UV filters on the example octyl methoxy cinnamate. International Journal of Pharmaceutics 258 (2003) 203-207
6. Pandey R., and Khuller G.K. Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis. Tuberculosis 85 (2005) 227-234
7. Sebti T., and Amighi K. Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation. European Journal of Pharmaceutics and Biopharmaceutics 63-1 (2006) 51-58
8. Wissing S.A., Kayser O., and Müller R.H. Solid lipid nanoparticles for parenteral drug delivery. Advanced Drug Delivery Reviews 56 (2004) 1257-1272
9. García-Fuentes M., Torres D., and Alonso M.J. Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Colloids and Surfaces B: Biointerfaces 27 2-3 (2003) 159-168
10. Humberstone A.J., and Charman W.N. Lipid-based vesicles for the oral delivery of poorly water soluble drugs. Advanced Drug Delivery Reviews 25 (1997) 103-128
11. Rasenack N., and Müller B.W. Micron-size drug particles: common and novel micronization techniques. Pharmaceutical Development and Technology 9 (2004) 1-13
12. Tom J.W., Lim G.B., Debendetti P.G., and Prud'homme R.K. Applications of supercritical fluids in controlled release of drugs. Supercritical Fluid Engineering Science, ACS Symposium Series, vol. 514. American Chemical Society (1993) 238
13. Jung J., and Perrut M. Particle design using supercritical fluids: literature and patent survey. The Journal of Supercritical Fluids 20 (2001) 179-219
14. Fages J., Lochard H., Letourneau J.-J., Sauceau M., and Rodier E. Particle generation for pharmaceutical applications using supercritical fluid technology. Powder Technology 141 (2004) 219-226
15. Sunkara G., and Kompella U.B. Drug delivery applications of supercritical fluid technology. Drug Delivery technology 2-1 January/February (2002)
16. Sinchaipanid N., Junyaprasert V., and Mitrevej A. Application of hot-melt coating for controlled release of propranolol hydrochloride pellets. Powder Technology 141 (2004) 203-209
17. Hamdani J., Moes A.J., and Amighi K. Development and evaluation of prolonged release pellets obtained by the melt pelletization process. International Journal of Pharmaceutics 245 (2002) 167-177
18. Qi S., Craig D.Q.M., and Marchaud D. An investigation into using spray chilled Gelucire 50/13 microspheres as potential drug carriers for poorly soluble drugs. Journal of Pharmacy and Pharmacology 58 Suppl. 1 (2006) A65-A66
19. Shimpi S.L., Chauhan B., Mahadik K.R., and Paradkar A. Stabilization and improved in vivo performance of amorphous etoricoxib using Gelucire 50/13. Pharmaceutical Research 22-10 (2005) 1727-1734
20. Mandzuka Z., and Knez Z. Influence of temperature and pressure during PGSS micronization and storage time on degree of crystallinity and crystal forms of monostearate and tristearate. The Journal of Supercritical Fluids 45 (2008) 102-111
21. Al-Omran F., and El-Khair A.A. Synthesis of polyfunctionally substituted heteroaromatic compounds via benzotriazolyl chalcones with antimicrobial and antifungal activities. Journal of Heterocycic Chemistry 41 (2004) 327-333
22. Boeck P., Leal P.C., Yunes R.A., Cechinel V.F., López S., Sortino M., Escalante A., Furlán R.L.E., and Zacchino S.L. Antifungal activity and studies on mode of action of novel xanthoxyline-derived chalcones. Archiv der Pharmazie 338 (2005) 87-95
23. Chen M., Zhai L., Christensen S.B., Theander T.G., and Kharazmi A. Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones. Antimicrobial Agents and Chemotherapy 45 (2001) 2023-2029
24. Nielsen S.F., Larsen M., Boesen T., Schønning K., and Kromann H. Cationic chalcone antibiotics. Design, synthesis, and mechanism of action. Journal of Medicinal Chemistry 48 (2005) 2667-2677
25. Valla A., Valla B., Cartier D., Le Guillou R., Labia R., Florent L., Charneau S., Schrevel J., and Potier P. New syntheses and potential antimalarial activities of new 'retinoid-like chalcones'. European Journal of Medicinal Chemistry 41 (2006) 142-146
26. De Leon E.J., Alcaraz M.J., Dominguez J.N., Charris J., and Terencio M.C. 1-(2,3,4-trimethoxyphenyl)-3-(3-(2-chloroquinolinyl))-2-propen-1-one, a chalcone derivative with analgesic, anti-inflammatory and immunomodulatory properties. Inflammation Research 52 (2003) 246-257
27. Viana G.S.B., Bandeira M.A.M., and Matos F.J.A. Analgesic and antiinflammatory effects of chalcones isolated from Myracrodruon urundeuva Allemao. Phytomedicine 10 (2003) 189-195
28. Nowakowska Z. A review of anti-infective and anti-inflammatory chalcones. European Journal of Medicinal Chemistry 42 2 (2007) 125-137
29. Won S., Liu C., Tsao L., Weng J., Ko H., Wang J., and Lin C. Synthetic chalcones as potential anti-inflammatory and cancer chemopreventive agents. European Journal of Medicinal Chemistry 40 1 (2005) 103-112
30. E. Weidner, Z. Knez, Z. Novak, Process for preparing particles or powders, Patent WO 9,521,688 (1995).
31. Sampaio de Sousa A.R., Calderone M., Rodier E., Fages J., and Duarte C.M.M. Solubility of carbon dioxide in three lipid-based biocarriers. The Journal of Supercritical Fluids 39 (2006) 13-19
32. 2, The Journal of Supercritical Fluids, accepted for publication.
33. A.R. Sampaio de Sousa, Development of functional particles using supercritical fluid technology, Ph.D. Thesis, Instituto de Tecnologia Química e Biológica, Portugal, 2007.
34. E.M. Burka, R. Curbelo, ATR imaging spectrometer, U.S. Patent 6,141,100 (2000).
35. Chan K.L.A., Hammond S.V., and Kazarian S.G. Applications of attenuated total reflection infrared spectroscopic imaging to pharmaceutical formulations. Analytical Chemistry 75 (2003) 2140-2146
36. Chan K.L.A., and Kazarian S.G. New opportunities in micro- and macro-attenuated total reflection infrared spectroscopic imaging: spatial resolution and sampling versatility. Applied Spectroscopy 57 (2003) 381-389